Home/Pipeline/HRAH-127*

HRAH-127*

Not Specified

Proof of Concept/Bench ValidationActive

Key Facts

Indication
Not Specified
Phase
Proof of Concept/Bench Validation
Status
Active
Company

About Hera Health Solutions

Hera Health Solutions is a private, pre-revenue biotech firm developing a tunable nanofiber-based drug delivery platform capable of sustained release from days to years. The company is advancing a pipeline of long-acting subcutaneous implants and patches, primarily in women's health and substance use disorder, through internal programs and co-development/licensing partnerships. Its strategy is to collaborate with pharmaceutical companies to reformulate existing APIs, leveraging FDA/GMP-approved materials and manufacturing for a potentially streamlined regulatory path.

View full company profile

Other Not Specified Drugs

DrugCompanyPhase
FL116Forlong BiotechnologyNot specified
FL117Forlong BiotechnologyNot specified
FL118Forlong BiotechnologyNot specified
FL301Forlong BiotechnologyNot specified
JSKN016AlphaMab OncologyPhase 1
JSKN033AlphaMab OncologyPhase 1
JSKN022AlphaMab OncologyPhase 1
JSKN027AlphaMab OncologyPhase 1
KN019AlphaMab OncologyPhase 1
New TCM FormulationsChina SXT PharmaceuticalsResearch / Pre-clinical
Long-acting LeronlimabCytoDynPreclinical
SR2162SIMR (Australia) BiotechIND Approved